Business Context and Reporting Period
Company: DaVita HealthCare Partners Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 5, 2016
Subject: Receipt of a Civil Investigative Demand (CID) by subsidiary DaVita Rx, LLC.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a legal contingency event.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses a new legal investigation initiated by the U.S. Attorney's Office for the Northern District of Texas.
Outlook, Risks, and Contingencies
- Investigation Details: The CID alleges violations of the False Claims Act regarding false claims for payment for prescription medications.
- Scope: The investigation covers the period from January 1, 2006, through the present.
- Management Response: The Company states it maintains compliance policies and intends to cooperate with the government.
- Uncertainty: Management explicitly states it cannot predict the resolution timeline, outcome, scope, or potential financial impact of the investigation.
Key Facts for Investor Verification
- Verify the specific allegations regarding prescription medication billing practices.
- Monitor future filings for updates on the investigation's scope or potential settlement amounts.
- Assess the potential impact of a False Claims Act violation on the Company's reputation and future revenue streams.
- Review the Company's historical compliance record regarding government healthcare programs.